"Handshake across the Himalayas"
India, China to study new ways to ease border tensions
India and China will study new ways to ease tensions along their ill-defined border, Chinese Premier Li Keqiang said on Monday in his first foreign trip since taking office, which comes just weeks after a military stand-off between the Asian giants in the Himalayas. Full Article | Slideshow
REUTERS SHOWCASE
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
GSK Consumer soars 20 pct on parent's open offer plan
Track Markets: BSE Sectoral Indices
Track and analyse performance of all BSE sectoral indices and other global indices on a single page. Full Coverage
A broker smiles as he trades on his computer terminal at a stock brokerage firm in Mumbai December 31, 2009.
Credit: Reuters/Punit Paranjpe/Files
MUMBAI |
MUMBAI (Reuters) - Shares in GlaxoSmithKline Consumer Healthcare (GLSM.NS), the Indian arm of GlaxoSmithKline (GSK.L), surged 20 percent to their maximum daily limit on Monday, following news that its UK-based parent group plans to raise its stake in the unit via an open offer.
GlaxoSmithKline Plc (GSK.L), along with its units, will buy up to 13.39 million shares, or an additional 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
Valued at $2.3 billion, shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20 percent to their maximum daily trading limit, while the Sensex was up 0.42 percent by 9:36 a.m. (Reporting by Kaustubh Kulkarni and Manoj Dharra; Editing by Jijo Jacob)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters